Orion Biotech Opportunities Corp. (ORIA) is a Blank Checks company listed on NASDAQ. There were no new wire items for ORIA in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
20 items- 13D/GSEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)SC 13G/A - Orion Biotech Opportunities Corp. (0001847416) (Subject)
- INSIDERSEC Form 4 filed by Collins James J.4 - Orion Biotech Opportunities Corp. (0001847416) (Issuer)
- INSIDERSEC Form 4 filed by Broder Samuel4 - Orion Biotech Opportunities Corp. (0001847416) (Issuer)
- INSIDERSEC Form 4 filed by Orion Sponsor Holdings, Llc4 - Orion Biotech Opportunities Corp. (0001847416) (Issuer)
- INSIDERSEC Form 4 filed by Rodriguez Louisa4 - Orion Biotech Opportunities Corp. (0001847416) (Issuer)
- SECSEC Form 15-12G filed by Orion Biotech Opportunities Corp.15-12G - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 25 filed by Orion Biotech Opportunities Corp.25 - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- NEWSOrion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination-SEC Filing
- SECOrion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 10-K filed by Orion Biotech Opportunities Corp.10-K - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 10-Q filed by Orion Biotech Opportunities Corp.10-Q - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 10-Q filed by Orion Biotech Opportunities Corp.10-Q - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 10-K filed by Orion Biotech Opportunities Corp.10-K - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- 13D/GSEC Form SC 13G filed by Orion Biotech Opportunities Corp.SC 13G - Orion Biotech Opportunities Corp. (0001847416) (Subject)
- SECSEC Form 10-Q/A filed by Orion Biotech Opportunities Corp. (Amendment)10-Q/A - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 425 filed by Orion Biotech Opportunities Corp.425 - Orion Biotech Opportunities Corp. (0001847416) (Subject)
- SECOrion Biotech Opportunities Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review8-K - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- SECSEC Form 10-Q filed by Orion Biotech Opportunities Corp.10-Q - Orion Biotech Opportunities Corp. (0001847416) (Filer)
- 13D/GSEC Form SC 13G filed by Orion Biotech Opportunities Corp.SC 13G - Orion Biotech Opportunities Corp. (0001847416) (Subject)
- SECSEC Form 10-Q filed by Orion Biotech Opportunities Corp.10-Q - Orion Biotech Opportunities Corp. (0001847416) (Filer)
ORIA FAQ
7 questionsWhat does Orion Biotech Opportunities Corp. do?
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.What is the latest news on ORIA?
Quantisnow has not tracked any new filings, ratings or press releases for ORIA in the last 30 days. The most recent wire item was published on February 14, 2024.Where does ORIA stock trade?
Orion Biotech Opportunities Corp. (ORIA) is listed on NASDAQ.What sector and industry is ORIA in?
Orion Biotech Opportunities Corp. operates in the Finance sector, Blank Checks industry.When did Orion Biotech Opportunities Corp. go public?
Orion Biotech Opportunities Corp. (ORIA) completed its IPO in 2021.What companies are similar to ORIA?
Notable peers in the same industry include PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), INV (Innventure Inc.), ILLU (Illumination Acquisition Corp I), TACO (Berto Acquisition Corp.). Compare ORIA side-by-side with any of them on Quantisnow.How can I track ORIA on Quantisnow?
Quantisnow aggregates Orion Biotech Opportunities Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ORIA to receive live email and push alerts on every new disclosure.